Brand Name: Advair Generic Name: Fluticasone Propionate
INDICATIONS
Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it is not designated for the relief an acute bronchospasm.
Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis : Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 250/50 it is designated for processing two times in day of need of obstruction of an air current at patients with COPD, connected with a chronic bronchitis.
Higher doses, switching Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 500/50, are not recommended. Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 250/50 mcg two times day - the unique approved dosage for processing COPD, connected to a chronic bronchitis.
Asthma : Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it is designated for long-term, two times day, processing maintenances of an asthma at patients 4 years of age and the grown-up.
Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it is not designated at patients, whose asthma can successfully be treated by inhaling corticosteroids alongside with infrequent application by inhaling, reacting{working} brevity beta 2 - agonists. By treating patients with an asthma, doctors should order only, that Generic ADVAIR DISKUS (Salmeterol/Fluticasone) for the patients who are not adequately controlled on other treatments of a regulator of an asthma (for example, low - to a dose of medium inhaled corticosteroids) or whose gravity of illness clearly guarantees initiation of processing with 2 maintenance therapies. For a long time reacting beta 2 - adrenergic agonists, such as salmeterol, one of active ingredients in Generic ADVAIR DISKUS (Salmeterol/Fluticasone), can increase risk of mors connected{linked} to an asthma. By treating patients with an asthma, doctors should order only, that Generic ADVAIR DISKUS (Salmeterol/Fluticasone) for the patients who are not adequately controlled on other treatments of a regulator of an asthma (for example, low - to a dose of medium inhaled corticosteroids) or whose gravity of illness clearly guarantees initiation of processing with 2 maintenance therapies.
ADMINISTRATION & DOSAGE
Directions for Use: Instructions of the Illustrated Patient for Utilization accompany with each package Generic ADVAIR DISKUS (Salmeterol/Fluticasone).
Geriatric Use: Based on the available data for Generic ADVAIR DISKUS (Salmeterol/Fluticasone) and its awake amounting, any adjustment of dosage is not recommended. In studies where geriatric patients (65 years of age or are more senior) were treated with Generic ADVAIR DISKUS (Salmeterol/Fluticasone), efficacyy and safety did not differ from it on minor to patients.
Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis: Dosage for adults - 1 inhalation (250/50 mcg) two times day (morning and evening, approximately on distance of 12 hours).
Higher doses, switching Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 500/50, are not recommended, as any padding convalescence of function of a lung has not been observed on clinical experiments, and higher doses of corticosteroids increase risk of systemic effects. Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 250/50 mcg two times day - the unique approved dosage for processing COPD, connected to a chronic bronchitis.
Asthma: Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it is not designated at patients, whose asthma can successfully be treated by inhaling corticosteroids alongside with infrequent application by inhaling, reacting brevity beta 2 - agonists. By treating patients with an asthma, doctors should order only, that Generic ADVAIR DISKUS (Salmeterol/Fluticasone) for the patients who are not adequately controlled on other treatments of a regulator of an asthma (for example, low - to a dose of medium inhaled corticosteroids) or whose gravity of illness clearly guarantees initiation of processing with 2 maintenance therapies. For a long time reacting beta 2 - adrenergic agonists, such as salmeterol, one of active ingredients in Generic ADVAIR DISKUS (Salmeterol/Fluticasone), can increase risk of mors connected to an asthma.
After inhalation, the patient should rinse a mouth with water without a swallowing. Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it should not be used to send patients from systemic therapy of a corticosteroid. Generic ADVAIR DISKUS (Salmeterol/Fluticasone) it should be applied by perorally inhaling route only (see. Instructions To use Generic ADVAIR DISKUS (Salmeterol/Fluticasone) in the Guide of Treatment concomitant a product).
Pediatric Patients: For patients in the age of 4 - 11 years which {who} are characteristic on an inhaling corticosteroid, dosage is 1 inhalation Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 100/50 two times day (morning and evening, approximately on distance of 12 hours).
Adult and Adolescent Patients 12 Years of Age and Older: For patients of 12 years of age also is more senior, dosage - 1 inhalation two times day (morning and evening, approximately on distance of 12 hours).
The maximum recommended, that dosage was Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 500/50 twice daily. For patients not now on inhaling corticosteroids which gravity of illness clearly guarantees, initiation of processing with 2 maintenance therapies, recommended launching{starting} dosage - Generic ADVAIR DISKUS (Salmeterol/Fluticasone) 100/50 or 250/50 two times day.
Recommended launching dosages for Generic ADVAIR DISKUS (Salmeterol/Fluticasone) for patients of 12 years of age also are more senior base on streaming therapy of an asthma of the patient.
- For the patients who are not adequately controlled on an inhaling corticosteroid.
|